p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China

World Journal of Gastroenterology

Volumn 10, Issue 19, 2004, Pages 2775-2778

  Lu, Xiao Mei ^a   Zhang, Yue Ming ^a   Lin, Ren Yong ^a   Liang, Xiao Hui ^a   Zhang, Ya Lou ^a   Wang, Xing ^a   Zhang, Yan ^a   Wang, Yan ^a   Wen, Hao ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN P53;

ALLELE; ARTICLE; CANCER RISK; CHINA; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESOPHAGUS CANCER; GENE AMPLIFICATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; WART VIRUS;

EID: 4644277974     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i19.2775     Document Type: Article

References (30)

1. Zhang YM. The distribution of esophageal cancer in Xinjiang. Xinjiang Yixueyuan Xuebao 1988; 11: 139-144
2. Liang YY, Esteve A, Martel-Planche G, Takahashi S, Lu SH, Montesano R, Hollstein M. p53 mutations in esophageal tumors from high-incidence areas of China. Int J Cancer 1995; 61: 611-614
3. Munoz N, Wahrendorf J, Bang LJ, Crespi M, Thurnham DI, Day NE, Ji ZH, Grassi A, Yan LW, Lin LG. No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China. Lancet 1985; 2: 111-114
4. Lin K, Shen W, Shen Z, Cai S, Wu Y. Estimation of the potential for nitrosation and its inhibition in subjects from high- and low-risk areas for esophageal cancer in southern China. Int J Cancer 2003; 10: 891-895
5. He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS, Tsao SW. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72: 959-964
6. Chen B, Yin H, Dhurandhar N. Detection of human papilloma-virus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum Pathol 1994; 25: 920-923
7. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136
8. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991; 10: 4129-4135
9. Huibregtse JM, Scheffner M, Howley PM. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 1993; 13: 4918-4927
10. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K. p53 polymorphism in human papillomavirus-associated esophageal cance. Cancer Research 2000; 60: 2753-2755
11. Peixoto Guimaraes D, Hsin Lu S, Snijders P, Wilmotte R, Herrero R, Lenoir G, Montesano R, Meijer CJ, Walboomers J, Hainaut P. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 2001; 162: 231-235
12. Lu ZM, Chen KN, Guo M. Detection of HPV in human esophageal cancer in high-incidence area and its correlation with p53 expression. Zhonghua Zhongliu Zazhi 2001; 23: 220-223
13. Zou SY, Si JY, Liu XM, Tang XP. PCR in detdction of human papillomavirus DNA in esophageal carcinoma in Xingjiang. Aizheng 1998; 17: 32-34
14. Greer CE, Whee Le CM, Manos MM. PCR Primer A Laboratory Manual. Cold Spring Harbor Laboratory Press 1995: 64-69
15. de la Calle-Martin O, Fabregat V, Romero M, Soler J, Vives J, Yague J. AccII Polymorphism of the p53 gene. Nucleic Acids Res 1990; 18: 4963
16. Chang F, Syrjanen S, Shen Q, Cintorino M, Santopietro R, Tosi P, Syrjanen K. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand J Gastroenterol 2000; 35: 123-130
17. Ojeda JM, Ampuero S, Rojas P, Prado R, Allende JE, Barton SA, Chakraborty R, Rothhammer F. p53 codon 72 polymorphism and risk of cervical cancer. Biol Res 2003; 36: 279-283
18. Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, Shrivastava S, Dinshaw K. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes patients from India. Gynecol Oncol 2002; 86: 157-162
19. Sifuentes Alvarez A, Reyes Romero M. Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care. Ginecol Obstet Mex 2003; 71: 12-15
20. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q, Ke Y. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95: 2571-2576
21. Humbey O, Cairey-Remonnay S, Guerrini JS, Algros MP, Mougin C, Bittard H, Aubin F. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer 2003; 39: 684-690
22. Inserra P, Abrahamsen M, Papenfuss M, Giuliano AR. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk. Int J STD AIDS 2003; 14: 800-804
23. Comar M, Molin GD, Guaschino S, Campello C. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy. Eur J Obstet Gynecol Reprod Biol 2004; 114: 210-214
24. Tanara G, Falugi C, Cesario A, Margaritora S, Russo P, Cosimi A. TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia. Int J Biol Markers 2003; 18: 280-283
25. Ngan HY, Liu VW, Liu SS, Cheng DK, Ng TY, Wong LC. Homozygous arginine at codon 72 of p53 has no prognostic significance in cervical cancer. Tumour Biol 2000; 21: 135-138
26. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
27. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-Protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505
28. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 1991; 88: 5523-5527
29. Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci U S A 2001; 98: 1218-1223
30. Vos M, Adams CH, Victor TC, van Helden PD. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 2003; 140: 23-30